Tumor anti-PD-L1 monoclonal antibody targeting TGF-beta1-siRNA nanoparticles and preparation method thereof
The invention provides a tumor anti-PD-L1 monoclonal antibody targeting TGF (Transforming Growth Factor)-beta 1-siRNA (Small Interference Ribonucleic Acid) nano particle and a preparation method thereof. The nano particle is formed by connecting a PD-L1 monoclonal antibody, polyethylene glycol and polycaprolactone to form a tumor anti-PD-L1 monoclonal antibody targeting drug-loading polymer PDL1-PEG-PCL and then physically wrapping TGF-beta 1-siRNA. The tumor anti-PD-L1 monoclonal antibody targeted TGF-beta1-siRNA nano particle is good in targeting property and small in toxic and side effects, and the preparation method of the tumor anti-PD-L1 monoclonal antibody targeted TGF-beta1-siRNA nano particle is simple in process, high in yield and few in side reaction..
Medienart: |
Patent |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Europäisches Patentamt - (2023) vom: 31. März Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Beteiligte Personen: |
WU FENGLEI [VerfasserIn] |
---|
Links: |
Volltext [kostenfrei] |
---|
Themen: |
Sonstige Themen: |
---|
Anmerkungen: |
Source: www.epo.org (no modifications made), First posted: 2023-03-31, Last update posted on www.tib.eu: 2023-06-21, Last updated: 2023-06-30 |
---|
Patentnummer: |
CN115869424 |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
EPA017324017 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | EPA017324017 | ||
003 | DE-627 | ||
005 | 20230630121303.0 | ||
007 | cr uuu---uuuuu | ||
008 | 230623s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)EPA017324017 | ||
035 | |a (EPA)CN115869424 | ||
035 | |a (EPA)85759996 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 0 | |a WU FENGLEI |e verfasserin |4 aut | |
245 | 1 | 0 | |a Tumor anti-PD-L1 monoclonal antibody targeting TGF-beta1-siRNA nanoparticles and preparation method thereof |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Source: www.epo.org (no modifications made), First posted: 2023-03-31, Last update posted on www.tib.eu: 2023-06-21, Last updated: 2023-06-30 | ||
520 | |a The invention provides a tumor anti-PD-L1 monoclonal antibody targeting TGF (Transforming Growth Factor)-beta 1-siRNA (Small Interference Ribonucleic Acid) nano particle and a preparation method thereof. The nano particle is formed by connecting a PD-L1 monoclonal antibody, polyethylene glycol and polycaprolactone to form a tumor anti-PD-L1 monoclonal antibody targeting drug-loading polymer PDL1-PEG-PCL and then physically wrapping TGF-beta 1-siRNA. The tumor anti-PD-L1 monoclonal antibody targeted TGF-beta1-siRNA nano particle is good in targeting property and small in toxic and side effects, and the preparation method of the tumor anti-PD-L1 monoclonal antibody targeted TGF-beta1-siRNA nano particle is simple in process, high in yield and few in side reaction. | ||
650 | 4 | |a A61P: Specific therapeutic activity of chemical compounds or medicinal preparations | |
650 | 4 | |a che | |
650 | 4 | |a A61K: Preparations for medical, dental, or toilet purposes (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms a61j0003000000;chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles a61l; soap compositions c11d) | |
650 | 4 | |a 615 | |
700 | 0 | |a SUN YUNLIANG |4 aut | |
700 | 0 | |a HU NAN |4 aut | |
700 | 0 | |a TIAN QINGSHUI |4 aut | |
700 | 0 | |a HONG YIDONG |4 aut | |
700 | 0 | |a ZHANG JINGZHOU |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Europäisches Patentamt |g (2023) vom: 31. März |
773 | 1 | 8 | |g year:2023 |g day:31 |g month:03 |
856 | 4 | 0 | |u https://worldwide.espacenet.com/patent/search/family/85759996/publication/CN115869424A1?q=CN115869424 |z kostenfrei |3 Volltext |
912 | |a GBV_EPA | ||
936 | u | w | |j 2023 |b 31 |c 03 |
951 | |a AR | ||
952 | |j 2023 |b 31 |c 03 |